India grapples with a rising diabetes epidemic, affecting younger demographics and leaving over 62% untreated. This has ...

With an increasing burden of diabetes in Singapore, digital innovations, research can help diabetics manage better. Read more ...

Modern medical innovations continue to transform treatment approaches for chronic conditions, and Ozempic stands at the ...

Chances are, you or someone you care about is living with persistent or chronic pain, often defined as pain that lasts for ...

Switching to a plant-based diet isn't just a lifestyle choice—it’s a powerful tool for better health. Learn how it can help ...

Two in three adults in England are overweight or obese - and 26 per cent of us have learned all we know about treatments like ...

The number of people living with diabetes worldwide has quadrupled in the past two decades, with 830 million people diagnosed ...

In an international trial of 713 adults in nine countries including the U.S. called SUMMIT, participants with heart failure ...

This syndrome plays a significant role in elevating the risk of developing cardiovascular diseases, which encompass serious ...

Despite the very positive setup facing Amgen as a result of its ongoing and future investments in developing new cardiometabolic medicines for big-ticket indications like obesity and type 2 diabetes, ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply lower Friday, after President-elect Donald Trump named Robert F. Kennedy Jr.